Position in PBH
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$838,758
-$86,802 QoQ
Shares Held
17,744
+13.6% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#29
of 116 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $10,662,030 across 14 Drug Manufacturers - Specialty & Generic names. PBH ranks #5 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
184,502 | $1,721,403 | |
| 2 | ALKS |
Alkermes plc.
|
25,815 | $1,352,576 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
35,789 | $1,212,531 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
47,850 | $1,177,588 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
This page
|
17,744 | $838,758 | |
| 6 | ZTS |
Zoetis Inc.
|
11,360 | $816,329 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
41,957 | $672,570 | |
| 8 | AKBA |
Akebia Therapeutics, Inc.
|
562,423 | $641,162 |
All Filings in PBH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $838,758 | 17,744 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $925,560 | 15,616 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $927,077 | 15,028 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $865,924 | 13,877 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,159,661 | 14,523 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $900,363 | 10,473 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,101,069 | 14,100 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $782,357 | 10,851 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $687,536 | 9,986 | Shares | Sole | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||